Related Experiment Video
Updated: May 14, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma
Sheng-Fei He1, Wen Wang, Hao Ren
1Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai 200433, China.
Abstract:
Signaling events triggered by interferon alpha (IFN-α) and ribavirin are involved in anti-hepatitis C virus (HCV) action. The p38 mitogen-activated protein kinase (MAPK) pathway plays an important role in HCV pathogenesis. Effects of IFN-α and ribavirin on p38 MAPK signaling were investigated in human hepatoma cells. Type I IFN receptor 2 (IFNAR2) mediated IFN-α-induced p38 MAPK phosphorylation. Also, p38 MAPK phosphorylation was enhanced by ribavirin. Treatment for 48 h with a combination of IFN-α and ribavirin increased p38 MAPK phosphorylation, whereas the treatment for 72 h reduced p38 MAPK phosphorylation. Cell culture-derived HCV (HCVcc) infection dramatically increased p38 MAPK phosphorylation and such phosphorylation was inhibited by IFN-α or ribavirin. Moreover, siRNA-mediated knockdown of p38 MAPK resulted in enhancement of ribavirin-dependent HCV RNA replication. These results suggest that regulation of p38 MAPK signaling by IFN-α and ribavirin might contribute to anti-HCV action.
Insights
Interferon alpha (IFN-α) and ribavirin regulate p38 MAPK signaling, impacting hepatitis C virus (HCV) infection. Modulating this pathway may enhance antiviral therapies against HCV.
Area of Science:
- Virology
- Cellular Signaling
- Hepatitis C Virus (HCV) Pathogenesis
Background:
- The p38 mitogen-activated protein kinase (MAPK) pathway is implicated in HCV pathogenesis.
- Interferon alpha (IFN-α) and ribavirin are key antiviral agents for HCV infection.
- Understanding their effects on cellular signaling is crucial for optimizing HCV treatment.
Purpose of the Study:
- To investigate the impact of IFN-α and ribavirin on p38 MAPK signaling in human hepatoma cells.
- To elucidate the role of p38 MAPK in HCV replication and its modulation by antiviral treatments.
Main Methods:
- Human hepatoma cells were treated with IFN-α and ribavirin, individually and in combination.
- p38 MAPK phosphorylation levels were assessed using Western blotting.
- siRNA-mediated knockdown of p38 MAPK was employed to study its functional role.
- HCV RNA replication was quantified following p38 MAPK knockdown.
Main Results:
- IFN-α induced p38 MAPK phosphorylation via Type I IFN receptor 2 (IFNAR2).
- Ribavirin enhanced p38 MAPK phosphorylation.
- Combined IFN-α and ribavirin treatment showed time-dependent effects on p38 MAPK phosphorylation.
- HCV infection increased p38 MAPK phosphorylation, which was inhibited by IFN-α or ribavirin.
- Knockdown of p38 MAPK enhanced ribavirin-dependent HCV RNA replication.
Conclusions:
- IFN-α and ribavirin modulate p38 MAPK signaling pathways.
- The regulation of p38 MAPK signaling by these antivirals may contribute to their anti-HCV effects.
- Targeting p38 MAPK could be a potential strategy in HCV therapy.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Hepatitis
The JAK-STAT Signaling Pathway

